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Abstract
Background: Previous studies revealed that reduction of airway caliber in infancy might increase the risks for wheezing and
asthma. However, the evidence for the predictive effects of pulmonary function on respiratory health in children was still
inconsistent.
Methods: We conducted a population-based prospective cohort study among children in 14 Taiwanese communities. There
were 3,160 children completed pulmonary function tests in 2007 and follow-up questionnaire in 2009. Poisson regression
models were performed to estimate the effect of pulmonary function on the development of bronchitis and asthma.
Results: After adjustment for potential confounders, pulmonary function indices consistently showed protective effects on
respiratory diseases in children. The incidence rate ratios of bronchitis and asthma were 0.86 (95% CI 0.79–0.95) and 0.91
(95% CI 0.82–0.99) for forced expiratory volume in 1 second (FEV1). Similar adverse effects of maximal mid-expiratory flow
(MMEF) were also observed on bronchitis (RR=0.73, 95% CI 0.67–0.81) and asthma (RR=0.85, 95% CI 0.77–0.93). We found
significant decreasing trends in categorized FEV1 (p for trend=0.02) and categories of MMEF (p for trend=0.01) for incident
bronchitis. Significant modification effects of traffic-related air pollution were noted for FEV1 and MMEF on bronchitis and
also for MMEF on asthma.
Conclusions: Children with high pulmonary function would have lower risks on the development of bronchitis and asthma.
The protective effect of high pulmonary function would be modified by traffic-related air pollution exposure.
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Introduction
Previous researches showed that bronchitis and asthma were
substantial respiratory health issues in children, which may
cause major childhood morbidity and high socioeconomic costs
[1,2]. Some studies have suggested a complex etiological
pathway for certain respiratory diseases but until now, definite
pathogenesis was still unclear [3]. There is growing evidence
that air pollution is an important environmental factor that may
be associated with childhood asthma [4,5]. Children with higher
prevalence of bronchitis resided in areas with higher ambient air
pollutants, such as nitrogen dioxide (NO2), has also been
reported [6,7]. In the previous finding from Taiwan Children
Health Study (TCHS), we found that risks of the microsomal
epoxide hydroxylase (EPHX1) gene for childhood respiratory
health could be modified by ambient NO2 levels [8], which
suggested that air pollution may overwhelm the genetic effects
and increase the risk of respiratory diseases in a subset of
children.
Pulmonary function is a sensitive marker of respiratory health,
which can detect and grade airway obstruction [9]. Bronchial
hyper-reactivity was an obvious characteristic of asthma and could
lead to the bronchial symptoms in both children and adults
[10,11]. Previous studies showed that high pulmonary function
indices such as the ratio of maximal mid-expiratory flow divided
by forced vital capacity (MMEF/FVC) and MMEF were inversely
associated with bronchial hyper-reactivity [12,13]. Although the
association between pulmonary function during the first few weeks
of life and onset of asthma in later life had been reported before
[14–16], evidence for the effect of pulmonary function on incident
respiratory diseases in school-aged children was inconclusive.
TCHS was a community-based longitudinal study that provided
information about genetics, respiratory health and environmental
factors, such as ambient air pollution. We had the opportunity to
assess the hypothesis that high pulmonary function indices are
associated with reduced risk of incident respiratory diseases. The
modification effect for traffic-related air pollution could also be
examined in the present study.
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Ethics approval
The study protocol was approved by the institutional review
board of our university hospital and complied with the principles
outlined in the Helsinki Declaration [17].
Study design
TCHS is a prospective cohort study examining the determi-
nants of children’s respiratory health, which focused on outdoor
air pollutants as primary interest. The study design and methods
for TCHS have been described in detail previously [7,18]. A total
of 4,134 seventh-grade children were recruited from public schools
from 14 communities. At cohort entry in 2007, all participants
were collected with baseline respiratory conditions and arranged
to complete pulmonary function tests. We followed these children
in 2009 with the identical questions concerning respiratory
diseases and pulmonary function tests. The mean follow-up period
for the current study was two years.
Questions regarding respiratory symptoms and diseases were
modified after those used in the Children’s Health Study in
southern California [19]. The outcomes of interest were
physician-diagnosed bronchitis and asthma. Children who were
disease-free at baseline and reported a yes answer to the question
‘‘Has a physician ever diagnosed your child as having
bronchitis?’’ on follow-up questionnaire were classified as having
incident bronchitis. The incident asthma was defined by the
question ‘‘Has a physician ever diagnosed your child as having
asthma?’’ on baseline and follow-up questionnaire. Those with
wheezing history but no diagnosis were considered to be at risk
for a new diagnosis of bronchitis or asthma and were included in
the study.
Pulmonary function measurement
Children’s pulmonary function tests (PFT) were performed
during the morning hours in indoor buildings to avoid daily and
annual peak air pollution levels. For the baseline survey in 2007,
children returned parental questionnaire were included. After
excluding subjects with incomplete questionnaire, recent
symptomatic upper respiratory infections, or other acute
pulmonary function or cardiac diseases, there were 3,261
children eligible for pulmonary function tests at the baseline
survey.
Each subject was requested to perform three satisfactory
blows, defined as both of the two largest FVC and forced
expiratory volume in 1 second (FEV1) agreeing within 150 ml,
extrapolation volume less than 150 ml or 5% of FVC, and forced
expiratory time exceeding 6 seconds. These criteria were based
on American Thoracic Society and European Respiratory
Society recommendations, updated in 2005, modified for
children [20]. No more than 5 blows were attempted per time,
no more than two times were asked per child. Resting for more
than 10 minutes was required for every subject to prevent
exercise bias. To predict subjects’ pulmonary function, height
and weight were measured at the time of testing. Two fully-
trained technicians performed PFT, using two spirometers
(Chestgraph HI-101, CHEST M.I., INC). Spirometers’ calibra-
tions were checked before, during, and after every morning’s
testing using 1L flow-volume syringes.
Three pulmonary function indices were analyzed: FVC,
FEV1 and MMEF. We obtained sex-specific percentage
predicted pulmonary function indices by using linear regression
models. The selection of the best prediction models from age,
h e i g h t ,n a t u r el o gv a l u e sf o rh e i g h t ,t h es q u a r eo fh e i g h t ,w e i g h t ,
nature log values for weight, the square of weight, body-mass
index, nature log values for body-mass index and the square of
body-mass index was based on the attained adjusted R
2 using
sex-specific equations (Table S1). We calculated each percent-
age predicted pulmonary function index from dividing the
observed values by the predicted values and was expressed in
percentage. Then, each percentage predicted pulmonary
function index was categorized into three groups based on the
cut-off points 90% and 110% that provided an adequate
distribution for analyses.
Figure 1. Annual average NO2 levels (2007–2009) in 14 Taiwan Children Health Study communities. Dark bars: higher NO2; mean, 22.1
ppb. Light bars: lower NO2; mean, 14.0 ppb.
doi:10.1371/journal.pone.0032477.g001
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Complete monitoring data for the criteria air pollutants are
available from Taiwan Environmental Protection Agency (EPA)
monitoring stations beginning in 1995. The average hourly levels
of NO2 were measured in 14 monitoring stations. We computed
the annual average of ambient NO2 levels between 2007 and
2009. The 14 communities were grouped by median NO2 level
into seven higher and seven lower ones (median level, 17.5 ppb).
The mean annual ambient NO2 level was 22.1 ppb in higher NO2
communities and 14.0 ppb in lower NO2 communities (Figure 1).
Table 1. Demographic characteristics of the study participants.
Selected characteristics at study entry
a Bronchitis-free cohort Asthma-free cohort
(N=2,893) (N=2,818)
n% n %
Gender
Boys 1466 51.5 1452 51.3
Girls 1380 48.5 1352 48.7
Age, yr
12 2254 79.5 2200 79.5
13 576 20.3 561 20.3
14 5 0.2 5 0.2
Parental income
b
400,000 943 35.9 930 36.3
410,000,800,000 1059 40.4 1031 40.3
810,000 622 23.7 598 23.4
Parental education, yr
12 1860 65.4 1813 65.3
13,15 554 19.5 547 19.7
16 432 15.2 417 15.0
Family history of asthma
Yes 69 2.4 55 2.0
Family history of atopy
c
Yes 663 23.3 655 23.6
In utero exposure to maternal smoking
Yes 110 3.9 103 3.7
Active smoking
Yes 149 5.2 145 5.2
Current SHS
Yes 1222 42.9 1209 43.5
Carpet use
Yes 254 9.0 252 9.1
Dogs in home
Yes 807 28.4 784 28.2
Cats in home
Yes 149 5.2 146 5.3
Cockroaches
Yes 2413 85.5 2367 85.9
Visible mould
Yes 963 34.1 957 34.7
Mildewy odor
Yes 416 14.7 413 14.9
Water stamp on the wall
Yes 718 25.4 711 25.7
aNumber of subjects do not add up to total N because of missing data.
bNew Taiwan dollars per year ($1 US=$ 33 New Taiwan).
cAtopy is defined as allergic rhinitis or atopic eczema.
doi:10.1371/journal.pone.0032477.t001
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The association between pulmonary function indices and the
incidence of bronchitis and asthma were examined by fitting
Poisson regression models (PROC GENMOD) with a logarithmic
link function. To account for over-dispersion of incidence rates in
Poisson models, we performed all analyses by using deviance
adjusted variance estimates [21]. On the basis of study design and
a priori consideration of potential confounders, we included in utero
exposure to maternal smoking, family history of asthma, family
history of atopy, and community in all models. If estimates of
pulmonary function indices changed by more than 10% when a
covariate was added in base models, the covariate would be
included in final models [22]. Subjects with missing covariate
information were included in the model using missing indicators
[23]. The incidence rate ratios were scaled by inter-quartile range
(IQR) increase of the corresponding values in certain pulmonary
function indices. We also conducted sensitivity analyses by
restricting the cohort to children without a history of bronchitis,
asthma or wheezing at study entry.
The influences of community-level air pollutants were estimated
by fitting two-stage hierarchical models. The models assumed two
sources of variation: the variation among subjects in the first stage,
part of which could be explained by the individual confounders,
and the variation of air pollution between communities in the
second stage, part of which could be explained by variables
measured at the community level. To investigate the effects of
traffic-related air pollution on the relationship between pulmonary
function indices and respiratory diseases, we conducted stratified
analysis comparing the children in communities with lower and
higher levels of NO2. We used likelihood ratio tests to examine the
interactive effects between pulmonary function indices and
ambient NO2 levels on respiratory diseases.
Wealso presented graphicallythe potentialmodificationeffectsof
traffic-related air pollution by plotting ambient NO2 levels on X-
axis and community-specific rate ratios on Y-axis. The regression
curves were drawn through the predicted values derived from
exponential regression models. All analyses were performed by SAS
software version 9.1 (SAS Institute, Gary, NC, USA) and assumed a
0.05 significant level based on a two-sided estimate.
Results
Participant characteristics
In 2009, a total of 3,160 children completed the follow-up
questionnaire and pulmonary function tests, with follow-up rate of
96.9%. There were 2,893 bronchitis-free children and 2,818
asthma-free children at cohort entry. The incidence rates were
8.1/1000 person-years for bronchitis and 7.2/1000 person-years
for asthma. The characteristics of study participants were shown in
Table 1. The proportion of gender was almost equal (51% male
and 49% female). Approximately 24% of the children had family
history of atopy which included any history of hay fever, allergies
to food or medicine, inhaled dusts, pollen, molds, animal fur or
dander, or skin allergies. The prevalence of current second-hand
smoke (SHS) and active smoke exposure were around 43% and
more than 5% among children. The distribution of all covariates
was consistent in the two disease-free cohorts.
Pulmonary function and respiratory diseases
The relationships between pulmonary function indices and
respiratory diseases were presented in Table 2. We found the
consistently protective effects for all pulmonary function indices.
Scaled across inter-quartile range elevation, the incidence rate
ratio of bronchitis was 0.86 (95% CI 0.7920.95) for FEV1 and
0.73 (95% CI 0.6720.81) for MMEF. Similar adverse effects were
observed for asthma with incidence rate ratio 0.90 (95% CI
0.8220.99) for FVC, 0.91 (95% CI 0.8220.99) for FEV1, and
0.85 (95% CI 0.7720.93) for MMEF. Restricting the analyses to
children without a history of bronchitis, asthma or wheezing did
not substantially alter the above findings (Table S2).
Table 3 presents the associations between pulmonary function
indices categories and incident bronchitis and asthma. The
incidence rate ratios for bronchitis and asthma were decreased
in the upper categories. In bronchitis-free cohort, significant
decreasing trends were found on categories of FEV1 (p for
trend=0.02) and on categories of MMEF (p for trend=0.01).
Table 2. Association between incident bronchitis and asthma
and pulmonary function indices at study entry.
Bronchitis Asthma
Pulmonary function index
a RR
b 95% CI RR
b 95% CI
FVC (% predicted) 1.08 0.99 – 1.18 0.90 0.82 – 0.99
FEV1 (% predicted) 0.86 0.79 – 0.95 0.91 0.82 – 0.99
MMEF (% predicted) 0.73 0.67 – 0.81 0.85 0.77 – 0.93
aFVC, forced vital capacity; FEV1, forced expiratory volume in 1s; MMEF, forced
expiratory flow over the mid-range of expiration.
bRelative risks (RR) and 95% confidence intervals (CI) of outcomes were scaled
across the inter-quartile range elevation by each pulmonary function index.
All models were adjusted for community, in utero exposure to maternal
smoking, family history of asthma, family history of atopy, active smoking and
current SHS.
doi:10.1371/journal.pone.0032477.t002
Table 3. Association between incident bronchitis and asthma
and pulmonary function indices categories at study entry.
Bronchitis Asthma
Pulmonary function
index* RR 95% CI RR 95% CI
FVC (% predicted)
90 1.00 1.00
90–110 1.55 1.16 – 2.06 0.93 0.71 – 1.22
110 0.78 0.52 – 1.16 0.72 0.50 – 1.03
p for trend 0.38 0.08
FEV1 (% predicted)
90 1.00 1.00
90–110 0.80 0.63 – 1.02 0.57 0.45 – 0.76
110 0.68 0.49 – 0.95 0.70 0.51 – 0.95
p for trend 0.02 0.01
MMEF (% predicted)
90 1.00 1.00
90–110 0.60 0.48 – 0.75 0.78 0.61 – 1.00
110 0.44 0.33 – 0.57 0.92 0.71 – 1.18
p for trend 0.01 0.47
*FVC, forced vital capacity;
FEV1, forced expiratory volume in 1s;
MMEF, forced expiratory flow over the mid-range of expiration.
All models were adjusted for community, in utero exposure to maternal
smoking, family history of asthma, family history of atopy, active smoking and
current SHS.
doi:10.1371/journal.pone.0032477.t003
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pulmonary function and respiratory diseases
We found loss of protective effects by each pulmonary function
index against bronchitis, chronic cough and asthma in the higher
NO2 communities (Table 4). Scaled across the inter-quartile range
elevation of FEV1, the incidence rate ratio of bronchitis was 0.56
(95% CI 0.49–0.65) in the lower NO2 communities, whereas the
effect was 1.10 (95% CI 0.96–1.24) in the higher NO2
communities (p for interaction=0.005). For each inter-quartile
range changes in MMEF, the effects on incident bronchitis were
0.43 (95% CI 0.37–0.50) in the lower NO2 communities and 0.96
(95% CI 0.85–1.10) in the higher NO2 communities (p for
interaction ,0.001). Similarly, the incidence rate ratio of asthma
was significantly lower in the lower NO2 communities (RR=0.73,
95% CI 0.64–0.83), compared with the effect in the higher NO2
communities (RR=0.97, 95% CI 0.85–1.11) (p for interac-
tion=0.04) (Table 4). In addition, we found no statistical
significant differences on the effects of pulmonary function indices
for incident bronchitis in relation to exposure to the other air
pollutants in TCHS (PM2.5,P M 10 and 8-hour O3). We calculated
the communities-specific rate ratios of each pulmonary function
index on incident bronchitis. The loss of protective effects from
high pulmonary function indices would be interpreted through
Figure 2, with significant interactions between pulmonary function
indices and ambient NO2 levels. We found the protective effects
would disappear in communities over ambient NO2 level of 25
ppb.
Discussion
We examined the relationship between pulmonary function and
respiratory diseases among children under different traffic-related
air pollutant levels. Pulmonary function indices, such as FEV1 and
MMEF, were found to predict the new-onset bronchitis and
asthma. Exposure to ambient NO2 would reduce the protective
effect of high pulmonary function on the occurrence of bronchitis.
To our best knowledge, this is the first report to describe the
association between pulmonary function indices and incident
bronchitis.
Our work is a prospective cohort study with a very high follow-
up rate (96.9%). The participants were representative of the native
population of Taiwan. Some individual characteristics, such as in
utero exposure to maternal smoking [24,25], family history of
asthma or atopy [26,27], and residential community may influence
the occurrence of asthma in childhood. Active smoking and
current SHS were also found to interfere in the association with
respiratory health [28–32]. We adjusted the above covariates in
Poisson regression models to minimize the confounding effects.
Some studies assessed the role of pulmonary function indices in
respiratory health. The airway caliber in infancy has been
reported as a decreasing risk for wheezing [16]. The association
Table 4. Relative risks of incident bronchitis and asthma by pulmonary function indices, stratified by community-specific annual
average NO2 levels (2007–2009).
Bronchitis Asthma
Low NO2
b High NO2
b interaction
p value Low NO2
b High NO2
b interaction
p value
Pulmonary
function index
a RR
c 95% CI RR
c 95% CI RR
c 95% CI RR
c 95% CI
FVC (% predicted) 0.83 0.72 – 0.95 1.25 1.10 – 1.42 0.12 0.82 0.72 – 0.93 1.00 0.88 – 1.14 0.40
FEV1 (% predicted) 0.56 0.49 – 0.65 1.10 0.96 – 1.24 0.005 0.85 0.75 – 0.97 0.94 0.82 – 1.08 0.47
MMEF (% predicted) 0.43 0.37 – 0.50 0.96 0.85 – 1.10 ,0.001 0.73 0.64 – 0.83 0.97 0.85 – 1.11 0.04
aFVC, forced vital capacity; FEV1, forced expiratory volume in 1s; MMEF, forced expiratory flow over the mid-range of expiration.
bTwo NO2 strata were defined as less than and greater than the median level (17.5 ppb).
cRelative risks (RR) and 95% confidence intervals (CI) of outcomes were scaled across the inter-quartile range elevation by each pulmonary function index.
All models were adjusted for community, in utero exposure to maternal smoking, family history of asthma, family history of atopy, active smoking and current SHS.
doi:10.1371/journal.pone.0032477.t004
Figure 2. Community-specific relative risks (RR) of incident bronchitis across inter-quartile range elevation for pulmonary function
indices by ambient NO2 levels. Each circle represents one community. (A) FVC, forced vital capacity; (B) FEV1, forced expiratory volume in 1s; (C)
MMEF, forced expiratory flow over the mid-range of expiration.
doi:10.1371/journal.pone.0032477.g002
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and asthma in later life had also been described [14,15]. In
previous epidemiological studies, high flow rates were noted to be
significantly correlated with a low prevalence of airway hyper-
reactivity [13,33], and age-related decline on prevalence of airway
hyper-reactivity was larger among those with higher FEV1% [34].
Furthermore, Islam et al. reported that high pulmonary function
provided protective effects in asthma development during
childhood [35]. The relationship of pulmonary function indices
on development of bronchitis in children has not been previously
investigated.
Pulmonary function indices have been clinically proved as
important phenotypes of respiratory health. Bronchial hyper-
reactivity could lead to the respiratory symptoms in childhood
[10,11]. In a previous cross-sectional study from the United States,
methacholine airway responsiveness was noted to be inversely
associated with high pulmonary function indices such as MMEF/
FVC [12]. Another hospital-based study from Italy also revealed
that MMEF was related to bronchial hyper-reactivity consistently
among patients with asthma and rhinitis [13]. All the above
evidences were consistent with our finding that pulmonary
function indices could well predict the occurrence of respiratory
diseases in childhood.
The respiratory system is particularly sensitive to air pollutants.
Traffic-related air pollution has been reported as a key factor for
the incidence of respiratory diseases [36]. NO2, the representative
traffic-related air pollutant, is through interaction with impairment
of respiratory response or the immune system to infection, and
damages the epithelial cells by oxidative injury [7,37,38]. In
Taiwan, we have previously reported that an increase of 8.79 ppb
of ambient NO2 exposure would result in 80% increase in the
prevalence of bronchitic symptoms [7]. We have interpreted our
data as a protective effect of high pulmonary function that was
attenuated by the effects of traffic-related air pollution (Table 4).
This finding was also consistent with previous analyses in our
cohort that the risk of respiratory morbidity associated with the
EPHX1 139Arg allele could be modified by ambient NO2 levels
[8]. The pathogenesis of bronchitis and asthma included airway
remodeling characterized by extraordinary mucous membrane
secretion and mild bronchial wall thickening. Long-term exposure
to higher level of air pollution has been noted to be associated with
small airway remodeling, followed by chronic bronchial obstruc-
tion [39]. It is likely that evolutionary selection has resulted in
pulmonary characteristics that lead to better respiratory health.
Higher pulmonary function may be a marker for lower
susceptibility to respiratory diseases.
Another concern for present study was the insufficient power to
detect relatively small modification effects of air pollution on
incident asthma. The primary pathophysiological characteristics of
bronchitis may include chronic pulmonary inflammation and
cellular oxidative stress [36], which might result from chemical
irritants such as NO2. The relatively higher predictive power for
bronchitis rather than asthma may be due to the essentially
different pathophysiology between these two kinds of diseases.
Our study has some limitations. The assessment of respiratory
diseases was based on questionnaire reports. Nevertheless,
questionnaire was widely used to define respiratory outcomes in
epidemiologic studies in children. Bronchitis and asthma were
through physician-diagnoses, which would reduce the possibility of
differential symptom identifications and recall bias. Another
limitation was the measurements of pulmonary function depend-
ing on many known or unknown factors, such as the quality of the
spirometry equipment, technician’s skill, and children’s coopera-
tion [9]. In order to avoid the possible errors of PFT
measurements, the children’s PFT were performed by the same
well-trained technicians and spirometers in indoor building within
the same season. We minimized these potential information biases
in our study design. It is possible that the cases of new-onset
bronchitis or asthma in our study were undiagnosed cases and had
low pulmonary function at study entry. This seems unlikely
because effect estimates did not changed substantially when we
restricted the analyses to children without a history of bronchitis,
asthma or wheezing. Because incident cases were defined without
knowledge of pulmonary function measurement, differential
misclassification is probably not a major source of bias that
accounts for our results.
In conclusion, our study provides new evidence for the
protective effects of high pulmonary function indices on incidence
of bronchitis and asthma. What is important to investigate is that
traffic-related air pollution is a substantial modifiable risk for
childhood respiratory diseases. Children living in communities
with higher traffic-related air pollution would suffer from increased
risks for new-onset bronchitis and asthma than those in lower
polluted communities. Additional research is necessary to clarify
the mechanism by NO2 modifies the protective effect of high
pulmonary function on the development of bronchitis and asthma.
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